Associations of SIRT3 and SIRT4 were in agreement with earlier reports about their effects on tumour suppression and on improved patient outcomes in hepatocellular carcinoma, and they are consistent with associations of higher SIRT3 expression levels with drug sensitivity in HCC cell lines [32]. Here, SIRT4 is linked to hepatocellular carcinoma.